Immune and mutational landscape in triple negative breast cancer and its evolution during neoadjuvant chemotherapy associated or not with GTN and anti-PD-1. (March 2019) - Mabrouk, N.; Racoeur, C.; Dondaine, L.; Shann, J.; Ghiringhelli, F.; Chouchane, L.; Bettaieb, A.; Paul, C.